TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Medlive Technology Co., Ltd. ( (HK:2192) ) just unveiled an announcement.
Medlive Technology Co., Ltd. announced an interim dividend of RMB 0.1166 per share for the six months ended 30 June 2025, with a payment date set for 25 September 2025. This announcement reflects the company’s financial health and commitment to providing returns to its shareholders, potentially strengthening its market position and investor confidence.
The most recent analyst rating on (HK:2192) stock is a Buy with a HK$16.50 price target. To see the full list of analyst forecasts on Medlive Technology Co., Ltd. stock, see the HK:2192 Stock Forecast page.
More about Medlive Technology Co., Ltd.
Medlive Technology Co., Ltd. operates in the technology sector, focusing on providing digital healthcare solutions and services. The company is known for its innovative approaches in the healthcare industry, aiming to enhance medical services and patient care through technology.
Average Trading Volume: 3,479,797
Technical Sentiment Signal: Buy
Current Market Cap: HK$10.59B
For a thorough assessment of 2192 stock, go to TipRanks’ Stock Analysis page.